Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Xipamid
1. 14293-44-8
2. 4-chloro-n-(2,6-dimethylphenyl)-2-hydroxy-5-sulfamoylbenzamide
3. Diurexan
4. Xipamid
5. Aquaphor
6. Diurex (lacer)
7. Aquaphor (diuretic)
8. Mjf 10,938
9. Be 1293
10. 4-chloro-5-sulfamoyl-2',6'-salicyloxylidide
11. Mjf-10938
12. Benzamide, 5-(aminosulfonyl)-4-chloro-n-(2,6-dimethylphenyl)-2-hydroxy-
13. Be-1293
14. 4s9ey0nuec
15. 2',6'-salicyloxylidide, 4-chloro-5-sulfamoyl-
16. 4-chlor-5-sulfamoyl-2',6'-salicyloxylidid
17. Xipamide (usan)
18. Ncgc00182543-01
19. Aquaphoril
20. Xipamide [usan]
21. Zipix
22. Aquaphor(tm), Original Formula Ointment Base
23. Dsstox_cid_3744
24. Dsstox_rid_77179
25. Dsstox_gsid_23744
26. Chronexan
27. Xipamida
28. Xipamidum
29. Xipamidum [inn-latin]
30. Xipamida [inn-spanish]
31. Xipamide [usan:inn:ban]
32. Cas-14293-44-8
33. Einecs 238-216-4
34. Unii-4s9ey0nuec
35. Mjf 10938
36. Brn 2778357
37. Lumitens
38. 4-chlor-5-sulfamoyl-2',6'-salicyloxylidid [german]
39. Xipamide [inn]
40. Xipamide [mi]
41. Xipamide [mart.]
42. Xipamide [who-dd]
43. Schembl43532
44. Chembl517199
45. Gtpl7900
46. Dtxsid5023744
47. Chebi:135499
48. Zinc538538
49. 4-chloro-n-(2,6-dimethylphenyl)-2-hydroxy-5-sulfamoyl-benzamide
50. Bei-1293
51. Tox21_112975
52. 5-(aminosulfonyl)-4-chloro-n-(2,6-dimethylphenyl)-2-hydroxybenzamide
53. Ac-911
54. Mfcd00865927
55. S5076
56. Akos015889012
57. Tox21_112975_1
58. Ccg-268092
59. Cs-w023041
60. Db13803
61. Ds-1401
62. Hy-w042301
63. Ncgc00182543-02
64. Ft-0659690
65. Ft-0675876
66. X0079
67. 4-chloro-5-sulfamoyl-2',6'-salicyloxilidide
68. 4-chloro-5-sulfamoyl-2?,6?-salicyloxylidide
69. D06341
70. 293x448
71. A807988
72. Q600951
73. Q-201936
74. 4-chloro-n-(2,6-dimethylphenyl)-2-hydroxy-5-sulphamoylbenzamide
75. 4-chloro-n-(2,6-dimethylphenyl)-2-hydroxy-5-sulfamoyl-benzamide;xipamide
76. 5-(aminosulfonyl)-4-chloro-n-(2,6-dimethylphenyl)-2-hydroxy-benzamide
77. 5-(aminosulfonyl)-4-chloro-n-(2,6-dimethylphenyl)-2-hydroxybenzamide #
78. Benzamide,5-(aminosulfonyl)-4-chloro-n-(2,6-dimethylphenyl)-2-hydroxy-
Molecular Weight | 354.8 g/mol |
---|---|
Molecular Formula | C15H15ClN2O4S |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 3 |
Exact Mass | 354.0441058 g/mol |
Monoisotopic Mass | 354.0441058 g/mol |
Topological Polar Surface Area | 118 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 526 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Diuretics
Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
C - Cardiovascular system
C03 - Diuretics
C03B - Low-ceiling diuretics, excl. thiazides
C03BA - Sulfonamides, plain
C03BA10 - Xipamide
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Xipamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Xipamide, including repackagers and relabelers. The FDA regulates Xipamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Xipamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Xipamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Xipamide supplier is an individual or a company that provides Xipamide active pharmaceutical ingredient (API) or Xipamide finished formulations upon request. The Xipamide suppliers may include Xipamide API manufacturers, exporters, distributors and traders.
click here to find a list of Xipamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Xipamide DMF (Drug Master File) is a document detailing the whole manufacturing process of Xipamide active pharmaceutical ingredient (API) in detail. Different forms of Xipamide DMFs exist exist since differing nations have different regulations, such as Xipamide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Xipamide DMF submitted to regulatory agencies in the US is known as a USDMF. Xipamide USDMF includes data on Xipamide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Xipamide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Xipamide suppliers with USDMF on PharmaCompass.
A Xipamide written confirmation (Xipamide WC) is an official document issued by a regulatory agency to a Xipamide manufacturer, verifying that the manufacturing facility of a Xipamide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Xipamide APIs or Xipamide finished pharmaceutical products to another nation, regulatory agencies frequently require a Xipamide WC (written confirmation) as part of the regulatory process.
click here to find a list of Xipamide suppliers with Written Confirmation (WC) on PharmaCompass.
Xipamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Xipamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Xipamide GMP manufacturer or Xipamide GMP API supplier for your needs.
A Xipamide CoA (Certificate of Analysis) is a formal document that attests to Xipamide's compliance with Xipamide specifications and serves as a tool for batch-level quality control.
Xipamide CoA mostly includes findings from lab analyses of a specific batch. For each Xipamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Xipamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Xipamide EP), Xipamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Xipamide USP).
LOOKING FOR A SUPPLIER?